 |
Atrasentan |
|---|---|
| Trade Name | |
| Orphan Indication | Focal segmental glomerulosclerosis |
| USA Market Approval | USA |
| USA Designation Date | 2016-09-29 00:00:00 |
| Sponsor | AbbVie Inc.;Regulatory Affairs, 1 North Waukegan Road;North Chicago, Illinois, 60044 |
| |
Atrasentan |
|---|---|
| Trade Name | |
| Orphan Indication | Focal segmental glomerulosclerosis |
| USA Market Approval | USA |
| USA Designation Date | 2016-09-29 00:00:00 |
| Sponsor | AbbVie Inc.;Regulatory Affairs, 1 North Waukegan Road;North Chicago, Illinois, 60044 |